Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Nov/14/2020 Nov/27/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/09/2020 Nov/24/2020 0
Raltegravir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/06/2020 Nov/24/2020 0
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 Nov/24/2020 0
Stavudine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 Nov/24/2020 0
Tenofovir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 Nov/24/2020 0
RBD-12GS-I53-50 Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020 Nov/24/2020 0
RBD-16GS-I53-50 Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020 Nov/24/2020 0